[
  {
    "title": "[互动]利德曼：公司目前没有生产新冠抗原检测产品",
    "href": "http://stock.jrj.com.cn/2022/12/19140137222190.shtml",
    "datetime": "2022-12-19 14:01:39",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：拟以2000万元投资联合医学、获其3.5088%的股权",
    "href": "http://stock.jrj.com.cn/2022/11/08195537121722.shtml",
    "datetime": "2022-11-08 19:55:21",
    "code": "300289"
  },
  {
    "title": "利德曼2022年前三季度净利3446.97万同比增长18.62% 投资收益增加",
    "href": "http://stock.jrj.com.cn/2022/10/21181137074032.shtml",
    "datetime": "2022-10-21 18:11:40",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)三季度净利1053.4万元 同比下降32.01%",
    "href": "http://stock.jrj.com.cn/2022/10/21161437073390.shtml",
    "datetime": "2022-10-21 16:14:34",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：拟以1.395亿元收购德赛系统余下30%股权、以1050万元收购德赛产品30%股权",
    "href": "http://stock.jrj.com.cn/2022/10/10204337045208.shtml",
    "datetime": "2022-10-10 20:43:08",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：子公司取得1项体外诊断试剂《医疗器械注册证》",
    "href": "http://stock.jrj.com.cn/2022/09/08154336983297.shtml",
    "datetime": "2022-09-08 15:43:59",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)半年度净利润2393.57万元 同比增长76.46%",
    "href": "http://stock.jrj.com.cn/2022/08/18160736911997.shtml",
    "datetime": "2022-08-18 16:07:30",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：补体C1q测定试剂盒(免疫比浊法)获批",
    "href": "http://stock.jrj.com.cn/2022/07/12174136803994.shtml",
    "datetime": "2022-07-12 17:41:37",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：生化诊断试剂新产品取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/05/25164636677828.shtml",
    "datetime": "2022-05-25 16:46:09",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：2021年年度权益分派10派0.2元 股权登记日5月18日",
    "href": "http://stock.jrj.com.cn/2022/05/10190836622782.shtml",
    "datetime": "2022-05-10 19:08:31",
    "code": "300289"
  },
  {
    "title": "利德曼2022年第一季度净利1210.91万同比增长93.14% 新冠检测试剂产品收入增加",
    "href": "http://stock.jrj.com.cn/2022/04/23183036437472.shtml",
    "datetime": "2022-04-23 18:30:41",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：一季度净利润增93.14%至1210.91万元",
    "href": "http://stock.jrj.com.cn/2022/04/22162336429109.shtml",
    "datetime": "2022-04-22 16:23:13",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：3项体外诊断试剂新产品取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/04/11164536304623.shtml",
    "datetime": "2022-04-11 16:45:14",
    "code": "300289"
  },
  {
    "title": "利德曼2021年净利2241.92万同比扭亏为盈 财务负责人欧阳旭薪酬51.74万",
    "href": "http://stock.jrj.com.cn/2022/03/18215134847464.shtml",
    "datetime": "2022-03-18 21:51:42",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)2021年度实现净利2241.92万元 拟10派0.2元",
    "href": "http://stock.jrj.com.cn/2022/03/18170734845694.shtml",
    "datetime": "2022-03-18 17:07:13",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2022/03/10171034809689.shtml",
    "datetime": "2022-03-10 17:10:14",
    "code": "300289"
  },
  {
    "title": "利德曼2021年预计净利1700万-2550万 较上年同期扭亏为盈",
    "href": "http://stock.jrj.com.cn/2022/01/26173034223851.shtml",
    "datetime": "2022-01-26 17:30:42",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)2021年度预盈1700万–2550万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2022/01/26162034223353.shtml",
    "datetime": "2022-01-26 16:20:16",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：获8项体外诊断试剂新产品注册证",
    "href": "http://stock.jrj.com.cn/2022/01/21190334183798.shtml",
    "datetime": "2022-01-21 19:03:24",
    "code": "300289"
  },
  {
    "title": "利德曼选举王凯翔为董事长 第三季度公司净利1549.36万",
    "href": "http://stock.jrj.com.cn/2021/12/01221133951923.shtml",
    "datetime": "2021-12-01 22:11:11",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：拟变更会计师事务所",
    "href": "http://stock.jrj.com.cn/2021/11/12172833841604.shtml",
    "datetime": "2021-11-12 17:28:11",
    "code": "300289"
  },
  {
    "title": "利德曼：前三季度净利润2905.78万元，同比增长481.39%",
    "href": "http://stock.jrj.com.cn/2021/10/29132633776541.shtml",
    "datetime": "2021-10-29 13:26:20",
    "code": "300289"
  },
  {
    "title": "利德曼前三季业绩预增380.2%-500.25% 研发投入需“快马加鞭”",
    "href": "http://stock.jrj.com.cn/2021/10/18090533709666.shtml",
    "datetime": "2021-10-18 09:05:00",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：第三季度净利预增18.66%-46.04%",
    "href": "http://stock.jrj.com.cn/2021/10/15183133699608.shtml",
    "datetime": "2021-10-15 18:31:59",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：董事于钦江不幸于近日因病去世",
    "href": "http://stock.jrj.com.cn/2021/10/10103833663211.shtml",
    "datetime": "2021-10-10 10:38:18",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：取得14项体外诊断试剂新产品的医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/08/13202733250494.shtml",
    "datetime": "2021-08-13 20:27:25",
    "code": "300289"
  },
  {
    "title": "利德曼2021年半年度净利1356.41万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/08/12200633244540.shtml",
    "datetime": "2021-08-12 20:06:49",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)半年度业绩扭亏为盈至1356.41万元",
    "href": "http://stock.jrj.com.cn/2021/08/12192033244284.shtml",
    "datetime": "2021-08-12 19:20:20",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：子公司获得欧盟CE证的相关新冠病毒检测试剂盒等未形成销售收入",
    "href": "http://stock.jrj.com.cn/2021/08/03211533197674.shtml",
    "datetime": "2021-08-03 21:15:23",
    "code": "300289"
  },
  {
    "title": "【龙虎榜】利德曼8月3日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/08/03180433196863.shtml",
    "datetime": "2021-08-03 18:04:10",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)上半年预盈1200万元-1500万元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2021/07/15114933100701.shtml",
    "datetime": "2021-07-15 11:49:47",
    "code": "300289"
  },
  {
    "title": "利德曼：公司在南方部分地区的营业收入有所下降 但公司在该地区的竞争力并未出现明显下降的情况",
    "href": "http://stock.jrj.com.cn/2021/06/22102632974966.shtml",
    "datetime": "2021-06-22 10:26:17",
    "code": "300289"
  },
  {
    "title": "利德曼：合资公司目前主要投资于生物医药等领域",
    "href": "http://stock.jrj.com.cn/2021/06/17221432950314.shtml",
    "datetime": "2021-06-17 22:14:55",
    "code": "300289"
  },
  {
    "title": "利德曼：公司目前不持有百济神州股份也尚未与其建立业务合作",
    "href": "http://stock.jrj.com.cn/2021/06/15162932934852.shtml",
    "datetime": "2021-06-15 16:29:37",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：拟延长向特定对象发行股票股东大会决议有效期及相关授权有效期",
    "href": "http://stock.jrj.com.cn/2021/06/09195532901100.shtml",
    "datetime": "2021-06-09 19:55:56",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：董事兼总裁张海涛辞职",
    "href": "http://stock.jrj.com.cn/2021/06/07161832887073.shtml",
    "datetime": "2021-06-07 16:18:27",
    "code": "300289"
  },
  {
    "title": "坏账计提陡降 利德曼再遭交易所问询 研发投入减少 扭亏能否持续？",
    "href": "http://stock.jrj.com.cn/2021/06/07084332885698.shtml",
    "datetime": "2021-06-07 08:43:00",
    "code": "300289"
  },
  {
    "title": "利德曼：樊桦先生于2020年底从利德曼子公司德赛系统离职后 在华大基因子公司担任相关职务",
    "href": "http://stock.jrj.com.cn/2021/06/01172732857738.shtml",
    "datetime": "2021-06-01 17:27:43",
    "code": "300289"
  },
  {
    "title": "利德曼聘任樊桦为公司副总裁",
    "href": "http://stock.jrj.com.cn/2021/05/28191732837098.shtml",
    "datetime": "2021-05-28 19:17:51",
    "code": "300289"
  },
  {
    "title": "利德曼：目前子公司德赛系统研发不涉及基因测序技术",
    "href": "http://stock.jrj.com.cn/2021/05/14191332756757.shtml",
    "datetime": "2021-05-14 19:13:34",
    "code": "300289"
  },
  {
    "title": "利德曼：公司未取得印度卫生部进口许可证尚不能在印度销售",
    "href": "http://stock.jrj.com.cn/2021/04/29212432482500.shtml",
    "datetime": "2021-04-29 21:24:14",
    "code": "300289"
  },
  {
    "title": "利德曼：公司现有的性激素六项对于生殖功能有重要的临床意义",
    "href": "http://stock.jrj.com.cn/2021/04/29212332482494.shtml",
    "datetime": "2021-04-29 21:23:29",
    "code": "300289"
  },
  {
    "title": "利德曼2020年亏损5098.37万由盈转亏 董事会秘书张丽华薪酬68万",
    "href": "http://stock.jrj.com.cn/2021/04/24175232435424.shtml",
    "datetime": "2021-04-24 17:52:52",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)2020年净亏损达5098.37万元 同比由盈转亏",
    "href": "http://stock.jrj.com.cn/2021/04/24121732434979.shtml",
    "datetime": "2021-04-24 12:17:14",
    "code": "300289"
  },
  {
    "title": "利德曼：公司研发的新冠病毒检测试剂盒未能在欧洲销售的主要原因是公司在海外市场的销售渠道资源相对有限",
    "href": "http://stock.jrj.com.cn/2021/04/19154432402037.shtml",
    "datetime": "2021-04-19 15:44:30",
    "code": "300289"
  },
  {
    "title": "利德曼：由于子公司在海外市场的销售渠道资源相对有限导致两款新冠检测试剂产品尚未实现销售",
    "href": "http://stock.jrj.com.cn/2021/04/19153832402007.shtml",
    "datetime": "2021-04-19 15:38:43",
    "code": "300289"
  },
  {
    "title": "利德曼业绩“变脸”迎上市首亏 近三年财务老大屡变、有两人都只干了3个多月",
    "href": "http://stock.jrj.com.cn/2021/04/16223632389129.shtml",
    "datetime": "2021-04-16 22:36:40",
    "code": "300289"
  },
  {
    "title": "利德曼业绩变脸迎上市首亏 近三年财务负责人多次变更",
    "href": "http://stock.jrj.com.cn/2021/04/16223632389127.shtml",
    "datetime": "2021-04-16 22:36:24",
    "code": "300289"
  },
  {
    "title": "利德曼：子公司阿匹斯有两款新冠检测试剂盒获得欧盟CE认证但尚未在国外形成销售收入",
    "href": "http://stock.jrj.com.cn/2021/04/15191032381091.shtml",
    "datetime": "2021-04-15 19:10:19",
    "code": "300289"
  },
  {
    "title": "【龙虎榜】利德曼3月3日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/03180332064610.shtml",
    "datetime": "2021-03-03 18:03:24",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：子公司广州利德曼重新签订房屋租赁合同",
    "href": "http://stock.jrj.com.cn/2021/03/02171232058121.shtml",
    "datetime": "2021-03-02 17:12:30",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：定增申请获证监会同意注册批复",
    "href": "http://stock.jrj.com.cn/2021/02/19183631993800.shtml",
    "datetime": "2021-02-19 18:36:16",
    "code": "300289"
  },
  {
    "title": "利德曼2020年预计净利550万-800万同比基本持平 门诊检验量同比减少",
    "href": "http://stock.jrj.com.cn/2021/01/29080331806477.shtml",
    "datetime": "2021-01-29 08:03:07",
    "code": "300289"
  },
  {
    "title": "利德曼：公司在生化诊断试剂领域具有产品多样、质量稳定、应用客户广泛等优势",
    "href": "http://stock.jrj.com.cn/2021/01/25204331768507.shtml",
    "datetime": "2021-01-25 20:43:41",
    "code": "300289"
  },
  {
    "title": "【龙虎榜】利德曼1月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/25180131767189.shtml",
    "datetime": "2021-01-25 18:01:44",
    "code": "300289"
  },
  {
    "title": "[利德曼]喜讯!利德曼医学参考实验室正式进入JCTLM参考测量服务实验室数据库",
    "href": "http://stock.jrj.com.cn/2021/01/25000031766507.shtml",
    "datetime": "2021-01-25 00:00:00",
    "code": "300289"
  },
  {
    "title": "【龙虎榜】利德曼1月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/22180331746247.shtml",
    "datetime": "2021-01-22 18:03:33",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：定增申请获深交所审核通过",
    "href": "http://stock.jrj.com.cn/2021/01/14091031688720.shtml",
    "datetime": "2021-01-14 09:10:43",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)取得两项生化诊断试剂产品《医疗器械注册证》",
    "href": "http://stock.jrj.com.cn/2020/12/25210331572516.shtml",
    "datetime": "2020-12-25 21:03:08",
    "code": "300289"
  },
  {
    "title": "利德曼：目前项目正在筹建中",
    "href": "http://stock.jrj.com.cn/2020/12/25130731568787.shtml",
    "datetime": "2020-12-25 13:07:54",
    "code": "300289"
  },
  {
    "title": "利德曼：公司化学发光产品的销售工作正在积极推进中",
    "href": "http://stock.jrj.com.cn/2020/12/04194331410083.shtml",
    "datetime": "2020-12-04 19:43:17",
    "code": "300289"
  },
  {
    "title": "利德曼股东沈广仟减持401万股 套现约2626.55万元",
    "href": "http://stock.jrj.com.cn/2020/12/01191531386339.shtml",
    "datetime": "2020-12-01 19:15:13",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：沈广仟减持完毕 累计减持401万股",
    "href": "http://stock.jrj.com.cn/2020/12/01115631383618.shtml",
    "datetime": "2020-12-01 11:56:35",
    "code": "300289"
  },
  {
    "title": "利德曼2020年前三季度净利499.79万下滑53.58% 抗击疫情对外捐赠以及支付补偿款",
    "href": "http://stock.jrj.com.cn/2020/10/29201231159214.shtml",
    "datetime": "2020-10-29 20:12:17",
    "code": "300289"
  },
  {
    "title": "利德曼2020年前三季度净利450万至550万 疫情对公司整体业绩冲击较大",
    "href": "http://stock.jrj.com.cn/2020/10/14232631054552.shtml",
    "datetime": "2020-10-14 23:26:41",
    "code": "300289"
  },
  {
    "title": "利德曼(300289.SZ)：前三季净利预降48.91%-58.20%",
    "href": "http://stock.jrj.com.cn/2020/10/14224431054519.shtml",
    "datetime": "2020-10-14 22:44:47",
    "code": "300289"
  },
  {
    "title": "利德曼：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/14200031053344.shtml",
    "datetime": "2020-10-14 20:00:09",
    "code": "300289"
  },
  {
    "title": "利德曼：拟设立的利德曼医疗科技暂不涉及跨境电商业务",
    "href": "http://stock.jrj.com.cn/2020/09/10143930721527.shtml",
    "datetime": "2020-09-10 14:39:23",
    "code": "300289"
  },
  {
    "title": "利德曼2020年上半年亏损595.76万由盈转亏 常规门诊检验量同比减少",
    "href": "http://stock.jrj.com.cn/2020/08/15121430504073.shtml",
    "datetime": "2020-08-15 12:14:28",
    "code": "300289"
  },
  {
    "title": "利德曼股东拟减持不超1%股份",
    "href": "http://stock.jrj.com.cn/2020/07/28175330364998.shtml",
    "datetime": "2020-07-28 17:53:04",
    "code": "300289"
  },
  {
    "title": "利德曼2020年上半年预计亏损400万元–800万元 生化诊断试剂销量下滑",
    "href": "http://stock.jrj.com.cn/2020/07/15001130242369.shtml",
    "datetime": "2020-07-15 00:11:16",
    "code": "300289"
  },
  {
    "title": "快讯：利德曼急速拉升9.69% 主力资金净流出6638.89万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/29135830086085.shtml",
    "datetime": "2020-06-29 13:58:01",
    "code": "300289"
  },
  {
    "title": "全资子公司新型冠状病毒检测产品完成CE认证 利德曼涨停",
    "href": "http://stock.jrj.com.cn/2020/06/24095430007229.shtml",
    "datetime": "2020-06-24 09:54:21",
    "code": "300289"
  },
  {
    "title": "[利德曼]阿匹斯科技两项新型冠状病毒检测产品完成CE认证",
    "href": "http://stock.jrj.com.cn/2020/06/24000030079875.shtml",
    "datetime": "2020-06-24 00:00:00",
    "code": "300289"
  },
  {
    "title": "快讯：利德曼急速拉升5.03% 主力资金净流入373.68万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/23095329996210.shtml",
    "datetime": "2020-06-23 09:53:22",
    "code": "300289"
  },
  {
    "title": "利德曼副总裁孙茜辞职 2019年薪酬为75万元",
    "href": "http://stock.jrj.com.cn/2020/06/01191829817179.shtml",
    "datetime": "2020-06-01 19:18:07",
    "code": "300289"
  },
  {
    "title": "利德曼股东沈广仟减持417万股 套现约2222.61万元",
    "href": "http://stock.jrj.com.cn/2020/05/19221429714584.shtml",
    "datetime": "2020-05-19 22:14:05",
    "code": "300289"
  },
  {
    "title": "利德曼董事钱震斌辞职 2019年度薪酬94.5万",
    "href": "http://stock.jrj.com.cn/2020/05/08215529621719.shtml",
    "datetime": "2020-05-08 21:55:27",
    "code": "300289"
  },
  {
    "title": "利德曼2020年第一季度亏损1547.29万由盈转亏 销售情况低于预期",
    "href": "http://stock.jrj.com.cn/2020/04/27235029398912.shtml",
    "datetime": "2020-04-27 23:50:57",
    "code": "300289"
  },
  {
    "title": "利德曼股东沈广仟拟减持股份 预计减持不超总股本1%",
    "href": "http://stock.jrj.com.cn/2020/04/17105029311788.shtml",
    "datetime": "2020-04-17 10:50:37",
    "code": "300289"
  },
  {
    "title": "利德曼：沈广仟计划减持不超过1%公司股份",
    "href": "http://stock.jrj.com.cn/2020/04/16204329307130.shtml",
    "datetime": "2020-04-16 20:43:48",
    "code": "300289"
  },
  {
    "title": "利德曼：股东沈广仟计划减持不超过1%公司股份",
    "href": "http://stock.jrj.com.cn/2020/04/16191229306711.shtml",
    "datetime": "2020-04-16 19:12:57",
    "code": "300289"
  },
  {
    "title": "利德曼2020年第一季度预计亏损1300万元–1700万元 常规门诊检验量同比减少",
    "href": "http://stock.jrj.com.cn/2020/04/09213729249499.shtml",
    "datetime": "2020-04-09 21:37:32",
    "code": "300289"
  },
  {
    "title": "利德曼：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/09174029247363.shtml",
    "datetime": "2020-04-09 17:40:00",
    "code": "300289"
  },
  {
    "title": "利德曼：股东沈广仟减持公司股份累计达5%",
    "href": "http://stock.jrj.com.cn/2020/03/25164629106657.shtml",
    "datetime": "2020-03-25 16:46:26",
    "code": "300289"
  },
  {
    "title": "利德曼：股东沈广仟减持公司股份达5%",
    "href": "http://stock.jrj.com.cn/2020/03/25164129106630.shtml",
    "datetime": "2020-03-25 16:41:08",
    "code": "300289"
  },
  {
    "title": "利德曼：股东减持公司股份达5%",
    "href": "http://stock.jrj.com.cn/2020/03/25163129106574.shtml",
    "datetime": "2020-03-25 16:31:00",
    "code": "300289"
  },
  {
    "title": "利德曼2019年净利580.23万减少85.66% 行业竞争加剧",
    "href": "http://stock.jrj.com.cn/2020/02/27234828909581.shtml",
    "datetime": "2020-02-27 23:48:49",
    "code": "300289"
  },
  {
    "title": "利德曼向湖北省捐赠100万元 为抗疫提供专项资金支持",
    "href": "http://stock.jrj.com.cn/2020/02/07125028792360.shtml",
    "datetime": "2020-02-07 12:50:28",
    "code": "300289"
  },
  {
    "title": "[利德曼]心系武汉|北京利德曼向湖北省捐赠100万元助力疫情防控",
    "href": "http://stock.jrj.com.cn/2020/02/07000028793139.shtml",
    "datetime": "2020-02-07 00:00:00",
    "code": "300289"
  },
  {
    "title": "利德曼：2019年年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2020/01/23133028727252.shtml",
    "datetime": "2020-01-23 13:30:00",
    "code": "300289"
  },
  {
    "title": "利德曼子公司德赛系统近日取得三项体外诊断试剂《医疗器械注册证》",
    "href": "http://stock.jrj.com.cn/2020/01/06172628631900.shtml",
    "datetime": "2020-01-06 17:26:18",
    "code": "300289"
  },
  {
    "title": "利德曼：子公司德赛系统取得三项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2020/01/06170028631748.shtml",
    "datetime": "2020-01-06 17:00:21",
    "code": "300289"
  },
  {
    "title": "利德曼：持股约13%的股东拟减持不超1%股份",
    "href": "http://stock.jrj.com.cn/2020/01/03191228626024.shtml",
    "datetime": "2020-01-03 19:12:39",
    "code": "300289"
  },
  {
    "title": "利德曼：股东拟减持公司不超1%股份",
    "href": "http://stock.jrj.com.cn/2020/01/03174728625287.shtml",
    "datetime": "2020-01-03 17:47:00",
    "code": "300289"
  },
  {
    "title": "利德曼取得体外诊断试剂《医疗器械注册证》",
    "href": "http://stock.jrj.com.cn/2019/12/31181428611567.shtml",
    "datetime": "2019-12-31 18:14:29",
    "code": "300289"
  },
  {
    "title": "利德曼股东沈广仟减持835万股 套现约4359万元",
    "href": "http://stock.jrj.com.cn/2019/12/12215628526571.shtml",
    "datetime": "2019-12-12 21:56:28",
    "code": "300289"
  },
  {
    "title": "利德曼股东沈广仟大宗交易减持1.9986%股份",
    "href": "http://stock.jrj.com.cn/2019/12/12180828525522.shtml",
    "datetime": "2019-12-12 18:08:21",
    "code": "300289"
  },
  {
    "title": "利德曼：股东大宗交易减持约2%股份",
    "href": "http://stock.jrj.com.cn/2019/12/12160228524943.shtml",
    "datetime": "2019-12-12 16:02:39",
    "code": "300289"
  },
  {
    "title": "利德曼：股东沈广仟大宗减持公司835万股",
    "href": "http://stock.jrj.com.cn/2019/12/12154828524903.shtml",
    "datetime": "2019-12-12 15:48:16",
    "code": "300289"
  },
  {
    "title": "利德曼终止收购科亦生物 涉足分子诊断领域受阻 业绩下陷还将继续？",
    "href": "http://stock.jrj.com.cn/2019/12/11082528517127.shtml",
    "datetime": "2019-12-11 08:25:00",
    "code": "300289"
  },
  {
    "title": "利德曼：终止收购科亦生物部分股权",
    "href": "http://stock.jrj.com.cn/2019/12/10200128515207.shtml",
    "datetime": "2019-12-10 20:01:18",
    "code": "300289"
  },
  {
    "title": "利德曼股东沈广仟减持417万股 套现约2499万元",
    "href": "http://stock.jrj.com.cn/2019/11/05091028352186.shtml",
    "datetime": "2019-11-05 09:10:27",
    "code": "300289"
  },
  {
    "title": "利德曼第三季度盈利260万 同比下滑88.61%",
    "href": "http://stock.jrj.com.cn/2019/10/25192628302012.shtml",
    "datetime": "2019-10-25 19:26:35",
    "code": "300289"
  },
  {
    "title": "利德曼2019年前三季度净利约1017万元-1117万元 子公司经营业绩下滑",
    "href": "http://stock.jrj.com.cn/2019/10/15160428250442.shtml",
    "datetime": "2019-10-15 16:04:43",
    "code": "300289"
  },
  {
    "title": "利德曼股东沈广仟拟减持股份 预计减持不超总股本1%",
    "href": "http://stock.jrj.com.cn/2019/10/10181228227833.shtml",
    "datetime": "2019-10-10 18:12:14",
    "code": "300289"
  },
  {
    "title": "利德曼：持股15.99%的股东拟减持不超1%",
    "href": "http://stock.jrj.com.cn/2019/10/09195628223306.shtml",
    "datetime": "2019-10-09 19:56:51",
    "code": "300289"
  },
  {
    "title": "利德曼：持股15.99%的股东沈广仟拟减持不超1%股份",
    "href": "http://stock.jrj.com.cn/2019/10/09190428223145.shtml",
    "datetime": "2019-10-09 19:04:40",
    "code": "300289"
  },
  {
    "title": "利德曼：股东拟减持不超1%股份",
    "href": "http://stock.jrj.com.cn/2019/10/09185528223138.shtml",
    "datetime": "2019-10-09 18:55:00",
    "code": "300289"
  },
  {
    "title": "[利德曼]喜讯:利德曼荣获“科技创新企业”及“畅融先锋企业”称号",
    "href": "http://stock.jrj.com.cn/2019/09/25000028185939.shtml",
    "datetime": "2019-09-25 00:00:00",
    "code": "300289"
  },
  {
    "title": "利德曼取得医疗器械注册证 增强公司在体外诊断领域的核心竞争力",
    "href": "http://stock.jrj.com.cn/2019/09/16175928136223.shtml",
    "datetime": "2019-09-16 17:59:53",
    "code": "300289"
  },
  {
    "title": "利德曼聘任程洋为公司财务负责人",
    "href": "http://stock.jrj.com.cn/2019/09/04080528086139.shtml",
    "datetime": "2019-09-04 08:05:10",
    "code": "300289"
  },
  {
    "title": "利德曼股东沈广仟解除质押385万股",
    "href": "http://stock.jrj.com.cn/2019/08/27135828040529.shtml",
    "datetime": "2019-08-27 13:58:24",
    "code": "300289"
  },
  {
    "title": "利德曼：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/08/19202027997892.shtml",
    "datetime": "2019-08-19 20:20:00",
    "code": "300289"
  },
  {
    "title": "[利德曼]“乘风.破浪.共创.辉煌”—利德曼2019年度团建活动圆满收官",
    "href": "http://stock.jrj.com.cn/2019/07/30000027903239.shtml",
    "datetime": "2019-07-30 00:00:00",
    "code": "300289"
  },
  {
    "title": "利德曼：2019年半年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2019/07/11233027829042.shtml",
    "datetime": "2019-07-11 23:30:00",
    "code": "300289"
  },
  {
    "title": "利德曼2019年上半年净利767万–844万 政府补助款到位",
    "href": "http://stock.jrj.com.cn/2019/07/11192227828263.shtml",
    "datetime": "2019-07-11 19:22:36",
    "code": "300289"
  },
  {
    "title": "利德曼股东拟减持公司股份不超过3%",
    "href": "http://stock.jrj.com.cn/2019/06/28211427771294.shtml",
    "datetime": "2019-06-28 21:14:00",
    "code": "300289"
  },
  {
    "title": "利德曼：合计持股18.98%的股东拟减持不超3%",
    "href": "http://stock.jrj.com.cn/2019/06/28204827771229.shtml",
    "datetime": "2019-06-28 20:48:01",
    "code": "300289"
  },
  {
    "title": "利德曼：沈广仟及一致行动人拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2019/06/28195627771001.shtml",
    "datetime": "2019-06-28 19:56:00",
    "code": "300289"
  },
  {
    "title": "利德曼：股东拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2019/06/28195427770979.shtml",
    "datetime": "2019-06-28 19:54:29",
    "code": "300289"
  },
  {
    "title": "利德曼：心衰标志物检测产品获医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2019/06/28123227769030.shtml",
    "datetime": "2019-06-28 12:32:51",
    "code": "300289"
  },
  {
    "title": "[利德曼]喜大普奔|全国首家全自动化学发光ST2测定试剂盒获批",
    "href": "http://stock.jrj.com.cn/2019/06/28000027768301.shtml",
    "datetime": "2019-06-28 00:00:00",
    "code": "300289"
  },
  {
    "title": "利德曼财务负责人王珩辞职 不再担任公司任何职务",
    "href": "http://stock.jrj.com.cn/2019/06/26080127756695.shtml",
    "datetime": "2019-06-26 08:01:36",
    "code": "300289"
  },
  {
    "title": "利德曼：终止回购公司股份",
    "href": "http://stock.jrj.com.cn/2019/06/25165027753464.shtml",
    "datetime": "2019-06-25 16:50:00",
    "code": "300289"
  },
  {
    "title": "利德曼：终止回购公司股份计划",
    "href": "http://stock.jrj.com.cn/2019/06/25164327753419.shtml",
    "datetime": "2019-06-25 16:43:45",
    "code": "300289"
  },
  {
    "title": "利德曼：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/04/27025027494544.shtml",
    "datetime": "2019-04-27 02:50:00",
    "code": "300289"
  },
  {
    "title": "利德曼去年净利4047万元 同比下滑45% 董事长林霖未在公司领取报酬",
    "href": "http://stock.jrj.com.cn/2019/04/24072827471797.shtml",
    "datetime": "2019-04-24 07:28:03",
    "code": "300289"
  },
  {
    "title": "[利德曼]喜讯:利德曼喜迎高新科控和诺诚健华来访 开展产业互动交流",
    "href": "http://stock.jrj.com.cn/2019/04/19000027432311.shtml",
    "datetime": "2019-04-19 00:00:00",
    "code": "300289"
  },
  {
    "title": "利德曼：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/04/09231027356641.shtml",
    "datetime": "2019-04-09 23:10:00",
    "code": "300289"
  },
  {
    "title": "利德曼股东沈广仟减持1262万股 套现约9856万元",
    "href": "http://stock.jrj.com.cn/2019/04/03074927311868.shtml",
    "datetime": "2019-04-03 07:49:07",
    "code": "300289"
  },
  {
    "title": "[利德曼]感恩有你 一路同行 丨利德曼-2019合作伙伴答谢会",
    "href": "http://stock.jrj.com.cn/2019/03/27000027251149.shtml",
    "datetime": "2019-03-27 00:00:00",
    "code": "300289"
  },
  {
    "title": "[利德曼]强强联手 共铸辉煌 | 利德曼与奥森多MPA项目正式上市",
    "href": "http://stock.jrj.com.cn/2019/03/20000027197714.shtml",
    "datetime": "2019-03-20 00:00:00",
    "code": "300289"
  },
  {
    "title": "利德曼：股东拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2019/03/07173127132157.shtml",
    "datetime": "2019-03-07 17:31:00",
    "code": "300289"
  },
  {
    "title": "利德曼：持股21.26%股东沈广仟拟减持不超3%",
    "href": "http://stock.jrj.com.cn/2019/03/07172627132115.shtml",
    "datetime": "2019-03-07 17:26:04",
    "code": "300289"
  },
  {
    "title": "[利德曼]喜讯:利德曼参考实验室正式通过CNAS认可!",
    "href": "http://stock.jrj.com.cn/2019/01/01000026885303.shtml",
    "datetime": "2019-01-01 00:00:00",
    "code": "300289"
  },
  {
    "title": "利德曼：凯得科技受让公司控制权获广州国资委同意",
    "href": "http://stock.jrj.com.cn/2018/11/26174025410053.shtml",
    "datetime": "2018-11-26 17:40:00",
    "code": "300289"
  },
  {
    "title": "公告精选：大连电瓷控股权将被拍卖；国资企业拟接盘欧浦智网、利德曼控股权",
    "href": "http://stock.jrj.com.cn/2018/11/09222925325028.shtml",
    "datetime": "2018-11-09 22:29:00",
    "code": "300289"
  },
  {
    "title": "利德曼：广州国资公司拟成为公司控股股东",
    "href": "http://stock.jrj.com.cn/2018/11/09204225324749.shtml",
    "datetime": "2018-11-09 20:42:15",
    "code": "300289"
  },
  {
    "title": "利德曼取得凝血四项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2018/10/19203225229839.shtml",
    "datetime": "2018-10-19 20:32:30",
    "code": "300289"
  },
  {
    "title": "利德曼前三季度净利润预增5%-15%",
    "href": "http://stock.jrj.com.cn/2018/10/09202425178297.shtml",
    "datetime": "2018-10-09 20:24:22",
    "code": "300289"
  },
  {
    "title": "利德曼：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/09201025178242.shtml",
    "datetime": "2018-10-09 20:10:00",
    "code": "300289"
  },
  {
    "title": "[利德曼]利德曼携手德赛参与2018NCLM检验盛宴",
    "href": "http://stock.jrj.com.cn/2018/09/21000025125660.shtml",
    "datetime": "2018-09-21 00:00:00",
    "code": "300289"
  },
  {
    "title": "控股股东拟变更为凯得科技 利德曼连续两日涨停",
    "href": "http://stock.jrj.com.cn/2018/08/21093024979556.shtml",
    "datetime": "2018-08-21 09:30:50",
    "code": "300289"
  },
  {
    "title": "控股股东拟变更为凯得科技 利德曼涨停",
    "href": "http://stock.jrj.com.cn/2018/08/20093424973807.shtml",
    "datetime": "2018-08-20 09:34:12",
    "code": "300289"
  },
  {
    "title": "利德曼控股股东拟转让控股权",
    "href": "http://stock.jrj.com.cn/2018/08/19181124970949.shtml",
    "datetime": "2018-08-19 18:11:40",
    "code": "300289"
  },
  {
    "title": "利德曼：控股股东签订《合作框架协议》",
    "href": "http://stock.jrj.com.cn/2018/08/19165524970799.shtml",
    "datetime": "2018-08-19 16:55:43",
    "code": "300289"
  },
  {
    "title": "利德曼：凯得科技拟9.9亿元受让控股股东所持不超29.9%股权 控股股东将变更",
    "href": "http://stock.jrj.com.cn/2018/08/19165524970801.shtml",
    "datetime": "2018-08-19 16:55:00",
    "code": "300289"
  },
  {
    "title": "[利德曼]利德曼成功举办2018年代理商技术工程师培训会",
    "href": "http://stock.jrj.com.cn/2018/08/15000024955343.shtml",
    "datetime": "2018-08-15 00:00:00",
    "code": "300289"
  },
  {
    "title": "[利德曼]利德曼盛大亮相2018美国芝加哥AACC博览会",
    "href": "http://stock.jrj.com.cn/2018/08/10000024937251.shtml",
    "datetime": "2018-08-10 00:00:00",
    "code": "300289"
  },
  {
    "title": "利德曼：关于非公开发行限售股份上市流通的提示性公告",
    "href": "http://stock.jrj.com.cn/2018/07/31205024886410.shtml",
    "datetime": "2018-07-31 20:50:00",
    "code": "300289"
  },
  {
    "title": "[利德曼]利德曼在2017年RELA试验中再获佳绩",
    "href": "http://stock.jrj.com.cn/2018/07/30000027010803.shtml",
    "datetime": "2018-07-30 00:00:00",
    "code": "300289"
  },
  {
    "title": "[利德曼]利德曼在2018年卫生部参考测量能力验证活动取得优异成绩",
    "href": "http://stock.jrj.com.cn/2018/07/30000027010804.shtml",
    "datetime": "2018-07-30 00:00:00",
    "code": "300289"
  },
  {
    "title": "[利德曼]利德曼在2017年RELA试验中再获佳绩",
    "href": "http://stock.jrj.com.cn/2018/07/27000024873399.shtml",
    "datetime": "2018-07-27 00:00:00",
    "code": "300289"
  },
  {
    "title": "[利德曼]利德曼在2018年卫生部参考测量能力验证活动取得优异成绩",
    "href": "http://stock.jrj.com.cn/2018/07/27000024873401.shtml",
    "datetime": "2018-07-27 00:00:00",
    "code": "300289"
  },
  {
    "title": "[利德曼]为促进医学装备领域发展,利德曼亮相POCT装备技术大会",
    "href": "http://stock.jrj.com.cn/2018/07/23000024850678.shtml",
    "datetime": "2018-07-23 00:00:00",
    "code": "300289"
  },
  {
    "title": "利德曼：拟5000万元-1亿元回购股份",
    "href": "http://stock.jrj.com.cn/2018/07/15162024817088.shtml",
    "datetime": "2018-07-15 16:20:55",
    "code": "300289"
  },
  {
    "title": "利德曼：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/07/11192024801154.shtml",
    "datetime": "2018-07-11 19:20:00",
    "code": "300289"
  },
  {
    "title": "利德曼2017年业绩稳定 营销渠道拓展驱动增长",
    "href": "http://stock.jrj.com.cn/2018/04/25211924452058.shtml",
    "datetime": "2018-04-25 21:19:00",
    "code": "300289"
  },
  {
    "title": "利德曼控股股东减持430万股",
    "href": "http://stock.jrj.com.cn/2018/02/14165224119566.shtml",
    "datetime": "2018-02-14 16:52:00",
    "code": "300289"
  },
  {
    "title": "利德曼：2017年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/01/29183024024792.shtml",
    "datetime": "2018-01-29 18:30:00",
    "code": "300289"
  },
  {
    "title": "利德曼：2017年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2017/10/13193023228945.shtml",
    "datetime": "2017-10-13 19:30:00",
    "code": "300289"
  },
  {
    "title": "利德曼终止筹划调整股权结构事项 25日起复牌",
    "href": "http://stock.jrj.com.cn/2017/08/24181222995512.shtml",
    "datetime": "2017-08-24 18:12:00",
    "code": "300289"
  },
  {
    "title": "8月11日午间公告：利德曼控股股东筹划重大事项 可能导致公司实控人变更",
    "href": "http://stock.jrj.com.cn/2017/08/11122822883282.shtml",
    "datetime": "2017-08-11 12:28:00",
    "code": "300289"
  },
  {
    "title": "利德曼遭遇闪崩 股价跌停",
    "href": "http://stock.jrj.com.cn/2017/06/02094922564722.shtml",
    "datetime": "2017-06-02 09:49:05",
    "code": "300289"
  },
  {
    "title": "利德曼受让赛德华23%股权",
    "href": "http://stock.jrj.com.cn/2017/05/10171322458638.shtml",
    "datetime": "2017-05-10 17:13:00",
    "code": "300289"
  },
  {
    "title": "利德曼控股股东拟减持不超850万股 占比2.01%",
    "href": "http://stock.jrj.com.cn/2016/12/08173121811661.shtml",
    "datetime": "2016-12-08 17:31:15",
    "code": "300289"
  },
  {
    "title": "利德曼通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2016/02/25121920607782.shtml",
    "datetime": "2016-02-25 12:19:38",
    "code": "300289"
  },
  {
    "title": "利德曼2015年净利润同比增长22.18%",
    "href": "http://stock.jrj.com.cn/2016/02/24162520603148.shtml",
    "datetime": "2016-02-24 16:25:43",
    "code": "300289"
  },
  {
    "title": "利德曼预计去年净利同比增长10%-30%",
    "href": "http://stock.jrj.com.cn/2016/01/15133720422485.shtml",
    "datetime": "2016-01-15 13:37:44",
    "code": "300289"
  },
  {
    "title": "三家公司并购重组今日上会 利德曼未获通过",
    "href": "http://stock.jrj.com.cn/2015/03/11191718949870.shtml",
    "datetime": "2015-03-11 19:17:31",
    "code": "300289"
  },
  {
    "title": "利德曼：入主德赛中国 欲做体外诊断龙头",
    "href": "http://stock.jrj.com.cn/2014/10/27142818241472.shtml",
    "datetime": "2014-10-27 14:28:54",
    "code": "300289"
  },
  {
    "title": "利德曼：生化诊断试剂品种齐全毛利率提升",
    "href": "http://stock.jrj.com.cn/2013/05/04095715275405.shtml",
    "datetime": "2013-05-04 09:57:07",
    "code": "300289"
  },
  {
    "title": "利德曼半年上涨50% 生化诊断前景广阔",
    "href": "http://stock.jrj.com.cn/hotstock/2012/11/07145114637937.shtml",
    "datetime": "2012-11-07 14:51:04",
    "code": "300289"
  },
  {
    "title": "利德曼:业绩符合预期 生化分析仪获批",
    "href": "http://stock.jrj.com.cn/hotstock/2012/10/22124914549839.shtml",
    "datetime": "2012-10-22 12:49:48",
    "code": "300289"
  },
  {
    "title": "利德曼：小盘高增长仍具爆发力",
    "href": "http://stock.jrj.com.cn/2012/08/24060814242590.shtml",
    "datetime": "2012-08-24 06:08:30",
    "code": "300289"
  },
  {
    "title": "利德曼上半年净利润4919万 增47%",
    "href": "http://stock.jrj.com.cn/2012/08/20184914195132.shtml",
    "datetime": "2012-08-20 18:49:16",
    "code": "300289"
  },
  {
    "title": "利德曼:中报业绩向上修正 维持“强烈推荐”",
    "href": "http://stock.jrj.com.cn/hotstock/2012/07/19125013848829.shtml",
    "datetime": "2012-07-19 12:50:17",
    "code": "300289"
  },
  {
    "title": "利德曼：上市不足5月两高管先后请辞",
    "href": "http://stock.jrj.com.cn/2012/07/03170113671018.shtml",
    "datetime": "2012-07-03 17:01:50",
    "code": "300289"
  },
  {
    "title": "利德曼768万限售股16日上市流通",
    "href": "http://stock.jrj.com.cn/2012/05/10202313072348.shtml",
    "datetime": "2012-05-10 20:23:17",
    "code": "300289"
  },
  {
    "title": "生物医药股多数飘绿 利德曼跌5.2%",
    "href": "http://stock.jrj.com.cn/invest/2012/02/17112412275019.shtml",
    "datetime": "2012-02-17 11:24:19",
    "code": "300289"
  },
  {
    "title": "新股定位：利德曼 均值区间：12.69元-15.36元",
    "href": "http://stock.jrj.com.cn/ipo/2012/02/16002112257445.shtml",
    "datetime": "2012-02-16 00:21:05",
    "code": "300289"
  },
  {
    "title": "利德曼公布网上定价发行中签号",
    "href": "http://stock.jrj.com.cn/ipo/2012/02/12193912224198.shtml",
    "datetime": "2012-02-12 19:39:00",
    "code": "300289"
  },
  {
    "title": "利德曼：股东涉嫌避税 应收账款管理混乱",
    "href": "http://stock.jrj.com.cn/2011/12/11103811802421.shtml",
    "datetime": "2011-12-11 10:38:41",
    "code": "300289"
  },
  {
    "title": "外资控股让位刚两年 利德曼“火速”IPO",
    "href": "http://stock.jrj.com.cn/2011/11/18024311586964.shtml",
    "datetime": "2011-11-18 02:43:00",
    "code": "300289"
  }
]